{"count": 3, "results": [{"_id": "35656292", "pmid": 35656292, "pmcid": "PMC9152216", "title": "Potential Role of Lisinopril in Reducing Atherosclerotic Risk: Evidence of an Antioxidant Effect in Human Cardiomyocytes Cell Line", "journal": "Front Pharmacol", "authors": ["Scisciola L", "Fontanella RA", "Surina", "Garofalo G", "Rizzo MR", "Paolisso G", "Barbieri M"], "date": "2022-05-17T00:00:00Z", "doi": "10.3389/fphar.2022.868365", "meta_date_publication": "2022", "meta_volume": "13", "meta_issue": "", "meta_pages": "868365", "score": 50267.324, "text_hl": "Potential Role of @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@Lisinopril@@@ in Reducing @<m>DISEASE_Atherosclerosis</m> @DISEASE_MESH:D050197 @@@Atherosclerotic@@@ Risk: Evidence of an Antioxidant Effect in @SPECIES_9606 @@@Human@@@ Cardiomyocytes Cell Line", "citations": {"NLM": "Scisciola L, Fontanella RA, Surina, Garofalo G, Rizzo MR, Paolisso G, Barbieri M. Potential Role of Lisinopril in Reducing Atherosclerotic Risk: Evidence of an Antioxidant Effect in Human Cardiomyocytes Cell Line Front Pharmacol. 2022;13():868365. PMID: 35656292", "BibTeX": "@article{35656292, title={Potential Role of Lisinopril in Reducing Atherosclerotic Risk: Evidence of an Antioxidant Effect in Human Cardiomyocytes Cell Line}, author={Scisciola L and Fontanella RA and Surina and Garofalo G and Rizzo MR and Paolisso G and Barbieri M}, journal={Front Pharmacol}, volume={13}, pages={868365}}"}}, {"_id": "24082511", "pmid": 24082511, "pmcid": "PMC3783684", "title": "Evaluation of Adverse Effects of Lisinopril and Rosuvastatin on Hematological and Biochemical Analytes in Wistar Rats", "journal": "Toxicol Int", "authors": ["Dodiya H", "Kale V", "Goswami S", "Sundar R", "Jain M"], "date": "2013-05-01T00:00:00Z", "doi": "10.4103/0971-6580.117261", "meta_date_publication": "2013 May", "meta_volume": "20", "meta_issue": "2", "meta_pages": "170-6", "score": 50076.07, "text_hl": "Combination therapy of @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ and @CHEMICAL_Rosuvastatin_Calcium @CHEMICAL_MESH:D000068718 @@@rosuvastatin@@@ may be an important concept in developing more effective strategies to treat and prevent @<m>DISEASE_Atherosclerosis</m> @DISEASE_MESH:D050197 @@@atherosclerosis@@@, @DISEASE_Coronary_Disease @DISEASE_MESH:D003327 @@@coronary heart disease@@@, and co-morbid @DISEASE_Metabolic_Diseases @DISEASE_MESH:D008659 @@@metabolic disorders@@@. ", "citations": {"NLM": "Dodiya H, Kale V, Goswami S, Sundar R, Jain M. Evaluation of Adverse Effects of Lisinopril and Rosuvastatin on Hematological and Biochemical Analytes in Wistar Rats Toxicol Int. 2013 May;20(2):170-6. PMID: 24082511", "BibTeX": "@article{24082511, title={Evaluation of Adverse Effects of Lisinopril and Rosuvastatin on Hematological and Biochemical Analytes in Wistar Rats}, author={Dodiya H and Kale V and Goswami S and Sundar R and Jain M}, journal={Toxicol Int}, volume={20}, number={2}, pages={170-6}}"}}, {"_id": "31477544", "pmid": 31477544, "title": "Cost-effectiveness of a fixed-dose combination pill for secondary prevention of cardiovascular disease in China, India, Mexico, Nigeria, and South Africa: a modelling study.", "journal": "Lancet Glob Health", "authors": ["Lin JK", "Moran AE", "Bibbins-Domingo K", "Falase B", "Pedroza Tobias A", "Mandke CN", "Kazi DS"], "date": "2019-10-01T00:00:00Z", "doi": "10.1016/S2214-109X(19)30339-0", "meta_date_publication": "2019 Oct", "meta_volume": "7", "meta_issue": "10", "meta_pages": "e1346-e1358", "score": 50035.22, "text_hl": "METHODS: We developed microsimulation models to assess the cost-effectiveness of a polypill containing @CHEMICAL_Aspirin @CHEMICAL_MESH:D001241 @@@aspirin@@@, @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@, @CHEMICAL_Atenolol @CHEMICAL_MESH:D001262 @@@atenolol@@@, and @CHEMICAL_Simvastatin @CHEMICAL_MESH:D019821 @@@simvastatin@@@ for secondary prevention of @<m>DISEASE_Atherosclerosis</m> @DISEASE_MESH:D050197 @@@atherosclerotic cardiovascular disease@@@ compared with current care in China, India, Mexico, Nigeria, and South Africa. ", "citations": {"NLM": "Lin JK, Moran AE, Bibbins-Domingo K, Falase B, Pedroza Tobias A, Mandke CN, Kazi DS. Cost-effectiveness of a fixed-dose combination pill for secondary prevention of cardiovascular disease in China, India, Mexico, Nigeria, and South Africa: a modelling study. Lancet Glob Health. 2019 Oct;7(10):e1346-e1358. PMID: 31477544", "BibTeX": "@article{31477544, title={Cost-effectiveness of a fixed-dose combination pill for secondary prevention of cardiovascular disease in China, India, Mexico, Nigeria, and South Africa: a modelling study.}, author={Lin JK and Moran AE and Bibbins-Domingo K and Falase B and Pedroza Tobias A and Mandke CN and Kazi DS}, journal={Lancet Glob Health}, volume={7}, number={10}, pages={e1346-e1358}}"}}]}